Does Day One Biopharmaceuticals Inc (NASDAQ:DAWN) Look Expensive At $13.77? Here’s How To Know.
In last trading session, Day One Biopharmaceuticals Inc (NASDAQ:DAWN) saw 0.61 million shares changing hands with its beta currently measuring -1.44. Company’s recent per share